THERAVANCE BIOPHARMA INC

Ticker: TBPH CUSIP: G8807B106 Class: Common Stock

Qube Research & Technologies Ltd's Holding History (CIK: 0001729829)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025

Shares 473,498 Value ($000) $8,859 Avg Close $16.59 Range $13.50 - $20.33

Q3 2025

Shares 211,048 Value ($000) $3,081 Avg Close $12.64 Range $10.82 - $14.87

Q2 2025

Shares 205,280 Value ($000) $2,264 Avg Close $9.72 Range $7.90 - $11.82

Q1 2025

Shares 113,939 Value ($000) $1,017 Avg Close $9.31 Range $8.35 - $10.90

Q3 2020

Shares 17,094 Value ($000) $253 Avg Close $18.73 Range $14.62 - $22.82

Q2 2020

Shares 13,123 Value ($000) $275 Avg Close $25.69 Range $20.17 - $31.35

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2025	473,498	$8,859	$16.59	$13.50 - $20.33
Q3 2025	211,048	$3,081	$12.64	$10.82 - $14.87
Q2 2025	205,280	$2,264	$9.72	$7.90 - $11.82
Q1 2025	113,939	$1,017	$9.31	$8.35 - $10.90
Q3 2020	17,094	$253	$18.73	$14.62 - $22.82
Q2 2020	13,123	$275	$25.69	$20.17 - $31.35